Table 2. Patient characteristics.
Patient no. | age | sex | diagnosis | Ig | DS stage | initial diagnosis | cytogenetic alterations |
---|---|---|---|---|---|---|---|
1 | 69 | ♀ | MM | κ light chains | IIIB | 06/2012 | del13q; t(4;14) |
2 | 61 | ♂ | MGUS | n.d. | n.d. | 2012 | n.d. |
3 | 73 | ♀ | MGUS | IgG κ | n.d. | n.d. | n.d. |
4 | 70 | ♀ | MM | IgA λ | II A | 01/2011 | n.d. |
5 | 80 | ♂ | MM | IgG κ | I | 07/2012 | n.d. |
6 | 41 | ♂ | MM | IgG κ | IIA | 12/2011 | hyperdiploid |
7 | 55 | ♂ | MM | IgG κ | n.d. | 08/2012 | normal |
9 | 71 | ♀ | MM | IgG κ | III A | 12/2011 | del13q |
10 | 62 | ♂ | MM | IgA λ | III A | n.d. | hyperdiploid |
11 | 64 | ♂ | MM | IgG κ | III A | 08/2012 | del13q |
12 | 62 | ♂ | MM | IgG κ | IIIA | 10/2012 | normal |
13 | 76 | ♂ | MM | IgG λ | III A | 10/2003 | normal |
14 | 64 | ♂ | MM | IgA κ | IA | 12/2002 | del13q |
15 | 73 | ♂ | MM | IgG κ | IIIA | 07/2006 | del13q; t(11;14) |
16 | 77 | ♂ | MM | λ light chains | n.d. | 06/2008 | n.d. |
17 | 65 | ♀ | MM | IgG λ | IIIB | 02/2009 | normal |
18 | 66 | ♂ | MM | IgG κ | IIA | 07/2006 | n.d. |
19 | 78 | ♂ | MM | IgG κ | IIA | 2006 | n.d. |
20 | 66 | ♀ | MM | IgG λ | IIIA | 1997 | del13q14; t(4;14) |
21 | 72 | ♂ | MM | IgG κ | IIIA | 04/1999 | n.d. |
22 | 53 | ♂ | MM | IgA λ | IIIB | 06/2007 | n.d. |
23 | 57 | ♀ | MM | IgG κ | IA | 06/2010 | del13q14; t(11;14) |
24 | 59 | ♂ | MM | IgG λ | IIIA | 04/2013 | t(11;14);t(14q32) tri13q14 |
25 | 73 | ♀ | MM | IgA κ | IIIA | 07/2013 | n.d. |
26 | 54 | ♀ | MM | IgG λ | II | 12/2008 | n.d. |